SEC Form 4 · accession 0001209191-18-003963
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian F Smith
Officer — EVP, COO
Period of report
Jan 16, 2018
Accepted (ET)
Jan 17, 2018 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 16, 2018 | M | 2,125 | $96.87 | D | 43,013 | D | |
| Common StockF2,F3 | Jan 16, 2018 | S | 825 | $155.80 | D | 42,188 | D | |
| Common StockF3,F4 | Jan 16, 2018 | S | 400 | $157.02 | D | 41,788 | D | |
| Common StockF3,F5 | Jan 16, 2018 | S | 400 | $158.11 | D | 41,388 | D | |
| Common StockF3,F6 | Jan 16, 2018 | S | 500 | $159.29 | D | 40,888 | D | |
| Common Stock | holding | — | — | — | 5,306 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $96.87 | Jan 16, 2018 | M | 2,125 | D | — | Jul 14, 2024 | Common Stock | 2,125 | 4,250 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $155.80 (range $155.32 to $156.26).
- F3Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $157.02 (range $156.62 to $157.50).
- F5Open market sales reported on this line occurred at a weighted average price of $158.11 (range $157.77 to $158.67).
- F6Open market sales reported on this line occurred at a weighted average price of $159.29 (range $158.96 to $159.65).
- F7The option vests in 16 quarterly installments from 7/15/2014.